Latest update on the European Commission’s investigation into possible state aid for the Hinkley point nuclear new-build project
On 18 December 2013, the European Commission decided to investigate alleged state aid by the UK into the nuclear new-build project at Hinkley point in Somerset. How has the UK responded to the opening of the investigation?
First, the UK states that it fully supports achieving the common EU objectives of decarbonisation, security of supply and diversity of supply at the lowest cost; but like many member states, we face unprecedented challenge in achieving these objectives. As the UK has concluded that new nuclear will help it achieve these objectives, it is an important part of our future energy mix.
However, the UK has also identified that there are genuine market failures. This means that optimal delivery of these objectives will not happen without state intervention to bring forward new nuclear capacity…
Click on the link below to read the rest of the Wragge & Co briefing.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from Wragge Lawrence Graham & Co
News from The Lawyer
Briefings from Wragge Lawrence Graham & Co
Arnold J has delivered a solution to the issue of a patent with claims in the ‘Swiss form’ but this is unlikely to be the last word in the saga. Life sciences companies – watch this space.
Last year there were positive and interesting developments regarding French capital gains tax applicable to non-French tax residents. News that these developments are now confirmed will be welcomed by many.